Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,031,196 papers from all fields of science
Search
Sign In
Create Free Account
Drug resistance
Known as:
Drug Resistance Process
, Drug resistance NOS
, drugs resistance
Expand
Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
35 relations
14-3-3 Protein Zeta/Delta
Adverse reaction to drug
BIRC6 gene
BIRC6 protein, human
Expand
Narrower (6)
Insulin Resistance
Multi-Drug Resistance
Tachyphylaxis
WARFARIN SENSITIVITY (disorder)
Expand
Broader (1)
Pharmacology
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences
Francesc Coll
,
R. McNerney
,
+16 authors
T. Clark
Genome Medicine
2015
Corpus ID: 8602979
Mycobacterium tuberculosis drug resistance (DR) challenges effective tuberculosis disease control. Current molecular tests…
Expand
Highly Cited
2015
Highly Cited
2015
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study
T. Walker
,
T. Kohl
,
+22 authors
Tim E. A. Peto
Lancet. Infectious Diseases (Print)
2015
Corpus ID: 3004029
Review
2014
Review
2014
Tumour heterogeneity and the evolution of polyclonal drug resistance
R. Burrell
,
C. Swanton
Molecular Oncology
2014
Corpus ID: 29970851
Review
2013
Review
2013
Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome
C. Maurice
,
Henry J. Haiser
,
P. Turnbaugh
Cell
2013
Corpus ID: 15712769
Highly Cited
2013
Highly Cited
2013
Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2…
E. Lawitz
,
Jay P Lalezari
,
+26 authors
A. Muir
Lancet. Infectious Diseases (Print)
2013
Corpus ID: 6984112
Review
2012
Review
2012
Discovery of small molecule cancer drugs: Successes, challenges and opportunities
S. Hoelder
,
P. Clarke
,
P. Workman
Molecular Oncology
2012
Corpus ID: 2568735
Highly Cited
2008
Highly Cited
2008
Induction of Pyruvate Dehydrogenase Kinase-3 by Hypoxia-inducible Factor-1 Promotes Metabolic Switch and Drug Resistance*
Chun‐Wun Lu
,
Shih-Chieh Lin
,
Ko-Fan Chen
,
Y. Lai
,
S. Tsai
Journal of Biological Chemistry
2008
Corpus ID: 38561089
The switch of cellular metabolism from mitochondrial respiration to glycolysis is the hallmark of cancer cells and associated…
Expand
Review
2003
Review
2003
HIV-1 protease: mechanism and drug discovery.
A. Brik
,
Chi‐Huey Wong
Organic and biomolecular chemistry
2003
Corpus ID: 15685420
It has now been two decades since acquired immunodeficiency syndrome (AIDS) was first reported by the US Center for Diseases…
Expand
Review
1996
Review
1996
P-glycoprotein--a mediator of multidrug resistance in tumour cells.
Ursula A. Germann
European Journal of Cancer
1996
Corpus ID: 10057643
Highly Cited
1994
Highly Cited
1994
Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
Padraic G. Fallon
,
M. Doenhoff
American Journal of Tropical Medicine and Hygiene
1994
Corpus ID: 9478650
Schistosoma mansoni infections in mice were treated with subcurative multiple doses of either praziquantel (PZQ) or oxamniquine…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE